Powered by

CMA accuses Actavis UK of overcharging NHS for hydrocortisone tablets

Dec 19, 2016 - Marketline Newswire

The UK's primary competition and consumer authority CMA has accused Actavis of overcharging the NHS for hydrocortisone tablets.

The UK's primary competition and consumer authority CMA has accused Actavis of overcharging the NHS for hydrocortisone tablets.These tablets are used as the primary replacement therapy for people whose adrenal glands do not produce enough natural steroid hormones.Actavis was formerly known as Auden Mckenzie and has increased the price of 10mg hydrocortisone tablet...